-
1
-
-
44349122993
-
Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: Tipping the scales of cancer
-
Frescas D, Pagano M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 2008; 8: 438-49.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 438-449
-
-
Frescas, D.1
Pagano, M.2
-
3
-
-
44449158749
-
The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4
-
Ahn Y, Hwang CY, Lee SR, Kwon KS, Lee C. The tumour suppressor PTEN mediates a negative regulation of the E3 ubiquitin-protein ligase Nedd4. Biochem J 2008; 412: 331-8.
-
(2008)
Biochem J
, vol.412
, pp. 331-338
-
-
Ahn, Y.1
Hwang, C.Y.2
Lee, S.R.3
Kwon, K.S.4
Lee, C.5
-
4
-
-
33748991453
-
Ubiquitin and ubiquitin-like proteins in cancer pathogenesis
-
Hoeller D, Hecker CM, Dikic I. Ubiquitin and ubiquitin-like proteins in cancer pathogenesis. Nat Rev Cancer 2006; 6: 776-88.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 776-788
-
-
Hoeller, D.1
Hecker, C.M.2
Dikic, I.3
-
5
-
-
63649086487
-
Targeting the ubiquitin system in cancer therapy
-
Hoeller D, Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 2009; 458: 438-44.
-
(2009)
Nature
, vol.458
, pp. 438-444
-
-
Hoeller, D.1
Dikic, I.2
-
6
-
-
67349132223
-
Physiological functions of the HECT family of ubiquitin ligases
-
Rotin D, Kumar S. Physiological functions of the HECT family of ubiquitin ligases. Nat Rev Mol Cell Biol 2009; 10: 398-409.
-
(2009)
Nat Rev Mol Cell Biol
, vol.10
, pp. 398-409
-
-
Rotin, D.1
Kumar, S.2
-
8
-
-
33646345376
-
Ubiquitin ligases: Cell-cycle control and cancer
-
Nakayama KI, Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 2006; 6: 369-81.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 369-381
-
-
Nakayama, K.I.1
Nakayama, K.2
-
9
-
-
80052069445
-
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis
-
Lipkowitz S, Weissman AM. RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis. Nat Rev Cancer 2011; 11: 629-43.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 629-643
-
-
Lipkowitz, S.1
Weissman, A.M.2
-
10
-
-
84878260314
-
Mechanisms and function of substrate recruitment by F-box proteins
-
Skaar JR, Pagan JK, Pagano M. Mechanisms and function of substrate recruitment by F-box proteins. Nat Rev Mol Cell Biol 2013; 14: 369-81.
-
(2013)
Nat Rev Mol Cell Biol
, vol.14
, pp. 369-381
-
-
Skaar, J.R.1
Pagan, J.K.2
Pagano, M.3
-
11
-
-
85027953065
-
Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer
-
Voutsadakis IA. Ubiquitination and the Ubiquitin-Proteasome System as regulators of transcription and transcription factors in epithelial mesenchymal transition of cancer. Tumour Biol 2012; 33: 897-910.
-
(2012)
Tumour Biol
, vol.33
, pp. 897-910
-
-
Voutsadakis, I.A.1
-
12
-
-
84873050284
-
Regulatory networks defining EMT during cancer initiation and progression
-
De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13: 97-110.
-
(2013)
Nat Rev Cancer
, vol.13
, pp. 97-110
-
-
De Craene, B.1
Berx, G.2
-
13
-
-
84903768676
-
Tackling the cancer stem cells-what challenges do they pose?
-
Pattabiraman DR, Weinberg RA. Tackling the cancer stem cells-what challenges do they pose? Nat Rev Drug Discov 2014; 13: 497-512.
-
(2014)
Nat Rev Drug Discov
, vol.13
, pp. 497-512
-
-
Pattabiraman, D.R.1
Weinberg, R.A.2
-
14
-
-
84894593599
-
Molecular mechanisms of epithelial-mesenchymal transition
-
Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15: 178-96.
-
(2014)
Nat Rev Mol Cell Biol
, vol.15
, pp. 178-196
-
-
Lamouille, S.1
Xu, J.2
Derynck, R.3
-
15
-
-
0032882919
-
Developmental expression of specific genes detected in high-quality cDNA libraries from single human preimplantation embryos
-
Adjaye J, Bolton V, Monk M. Developmental expression of specific genes detected in high-quality cDNA libraries from single human preimplantation embryos. Gene 1999; 237: 373-83.
-
(1999)
Gene
, vol.237
, pp. 373-383
-
-
Adjaye, J.1
Bolton, V.2
Monk, M.3
-
16
-
-
84866360452
-
EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas
-
Al Moustafa AE, Achkhar A, Yasmeen A. EGF-receptor signaling and epithelial-mesenchymal transition in human carcinomas. Front Biosci (Schol Ed) 2012; 4: 671-84.
-
(2012)
Front Biosci (Schol Ed)
, vol.4
, pp. 671-684
-
-
Al Moustafa, A.E.1
Achkhar, A.2
Yasmeen, A.3
-
17
-
-
84895057195
-
FGF receptors: Cancer biology and therapeutics
-
Katoh M, Nakagama H. FGF receptors: cancer biology and therapeutics. Med Res Rev 2014; 34: 280-300.
-
(2014)
Med Res Rev
, vol.34
, pp. 280-300
-
-
Katoh, M.1
Nakagama, H.2
-
18
-
-
84906255314
-
High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients
-
Canadas I, Taus A, Gonzalez I, et al. High circulating hepatocyte growth factor levels associate with epithelial to mesenchymal transition and poor outcome in small cell lung cancer patients. Oncotarget 2014; 5: 5246-56.
-
(2014)
Oncotarget
, vol.5
, pp. 5246-5256
-
-
Canadas, I.1
Taus, A.2
Gonzalez, I.3
-
19
-
-
84902077145
-
HGF induces epithelial-tomesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways
-
Farrell J, Kelly C, Rauch J, et al. HGF induces epithelial-tomesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways. J Proteome Res 2014; 13: 2874-86.
-
(2014)
J Proteome Res
, vol.13
, pp. 2874-2886
-
-
Farrell, J.1
Kelly, C.2
Rauch, J.3
-
20
-
-
84890227134
-
Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway
-
Wu Q, Wang R, Yang Q, et al. Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway. Oncotarget 2013; 4: 1999-2009.
-
(2013)
Oncotarget
, vol.4
, pp. 1999-2009
-
-
Wu, Q.1
Wang, R.2
Yang, Q.3
-
21
-
-
84878905949
-
Emerging roles of PDGF-D in EMT progression during tumorigenesis
-
Wu Q, Hou X, Xia J, et al. Emerging roles of PDGF-D in EMT progression during tumorigenesis. Cancer Treat Rev 2013; 39: 640-6.
-
(2013)
Cancer Treat Rev
, vol.39
, pp. 640-646
-
-
Wu, Q.1
Hou, X.2
Xia, J.3
-
23
-
-
34249289041
-
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype
-
Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-28.
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 415-428
-
-
Peinado, H.1
Olmeda, D.2
Cano, A.3
-
24
-
-
84897942238
-
F-box protein complex FBXL19 regulates TGFbeta1-induced E-cadherin down-regulation by mediating Rac3 ubiquitination and degradation
-
Dong S, Zhao J, Wei J, et al. F-box protein complex FBXL19 regulates TGFbeta1-induced E-cadherin down-regulation by mediating Rac3 ubiquitination and degradation. Mol Cancer 2014; 13: 76.
-
(2014)
Mol Cancer
, vol.13
-
-
Dong, S.1
Zhao, J.2
Wei, J.3
-
25
-
-
84898848726
-
FBXL20 acts as an invasion inducer and mediates E-cadherin in colorectal adenocarcinoma
-
Zhu J, Deng S, Duan J, et al. FBXL20 acts as an invasion inducer and mediates E-cadherin in colorectal adenocarcinoma. Oncol Lett 2014; 7: 2185-91.
-
(2014)
Oncol Lett
, vol.7
, pp. 2185-2191
-
-
Zhu, J.1
Deng, S.2
Duan, J.3
-
26
-
-
33845724527
-
VHL promotes E2 boxdependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail
-
Evans AJ, Russell RC, Roche O, et al. VHL promotes E2 boxdependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol 2007; 27: 157-69.
-
(2007)
Mol Cell Biol
, vol.27
, pp. 157-169
-
-
Evans, A.J.1
Russell, R.C.2
Roche, O.3
-
27
-
-
33645748171
-
Regulation of E-cadherin expression by VHL and hypoxia-inducible factor
-
Esteban MA, Tran MG, Harten SK, et al. Regulation of E-cadherin expression by VHL and hypoxia-inducible factor. Cancer Res 2006; 66: 3567-75.
-
(2006)
Cancer Res
, vol.66
, pp. 3567-3575
-
-
Esteban, M.A.1
Tran, M.G.2
Harten, S.K.3
-
28
-
-
33749188859
-
MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation
-
Yang JY, Zong CS, Xia W, et al. MDM2 promotes cell motility and invasiveness by regulating E-cadherin degradation. Mol Cell Biol 2006; 26: 7269-82.
-
(2006)
Mol Cell Biol
, vol.26
, pp. 7269-7282
-
-
Yang, J.Y.1
Zong, C.S.2
Xia, W.3
-
29
-
-
0033602227
-
The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell
-
Hart M, Concordet JP, Lassot I, et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr Biol 1999; 9: 207-10.
-
(1999)
Curr Biol
, vol.9
, pp. 207-210
-
-
Hart, M.1
Concordet, J.P.2
Lassot, I.3
-
30
-
-
0033034120
-
Beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation
-
Liu C, Kato Y, Zhang Z, et al. beta-Trcp couples beta-catenin phosphorylation-degradation and regulates Xenopus axis formation. Proc Natl Acad Sci USA 1999; 96: 6273-8.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 6273-6278
-
-
Liu, C.1
Kato, Y.2
Zhang, Z.3
-
31
-
-
0034643433
-
Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system
-
Sadot E, Simcha I, Iwai K, et al. Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system. Oncogene 2000; 19: 1992-2001.
-
(2000)
Oncogene
, vol.19
, pp. 1992-2001
-
-
Sadot, E.1
Simcha, I.2
Iwai, K.3
-
32
-
-
67649746319
-
The F-box protein beta-TrCp1/Fbw1a interacts with p300 to enhance beta-catenin transcriptional activity
-
Kimbrel EA, Kung AL. The F-box protein beta-TrCp1/Fbw1a interacts with p300 to enhance beta-catenin transcriptional activity. J Biological Chem 2009; 284: 13033-44.
-
(2009)
J Biological Chem
, vol.284
, pp. 13033-13044
-
-
Kimbrel, E.A.1
Kung, A.L.2
-
33
-
-
84865712651
-
Fas-associated factor 1 is a scaffold protein that promotes beta-transducin repeat-containing protein (beta-TrCP)-mediated beta-catenin ubiquitination and degradation
-
Zhang L, Zhou F, Li Y, et al. Fas-associated factor 1 is a scaffold protein that promotes beta-transducin repeat-containing protein (beta-TrCP)-mediated beta-catenin ubiquitination and degradation. J Biological Chem 2012; 287: 30701-10.
-
(2012)
J Biological Chem
, vol.287
, pp. 30701-30710
-
-
Zhang, L.1
Zhou, F.2
Li, Y.3
-
34
-
-
56849086074
-
APC is essential for targeting phosphorylated beta-catenin to the SCFbeta-TrCP ubiquitin ligase
-
Su Y, Fu C, Ishikawa S, et al. APC is essential for targeting phosphorylated beta-catenin to the SCFbeta-TrCP ubiquitin ligase. Mol Cell 2008; 32: 652-61.
-
(2008)
Mol Cell
, vol.32
, pp. 652-661
-
-
Su, Y.1
Fu, C.2
Ishikawa, S.3
-
35
-
-
84896319727
-
E3-ligase Skp2 regulates betacatenin expression and maintains hematopoietic stem cell homing
-
Wang J, Han F, Lee SW, et al. E3-ligase Skp2 regulates betacatenin expression and maintains hematopoietic stem cell homing. Biochem Biophys Res Commun 2014; 445: 566-71.
-
(2014)
Biochem Biophys Res Commun
, vol.445
, pp. 566-571
-
-
Wang, J.1
Han, F.2
Lee, S.W.3
-
36
-
-
81555196348
-
The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewal
-
Wang J, Han F, Wu J, et al. The role of Skp2 in hematopoietic stem cell quiescence, pool size, and self-renewal. Blood 2011; 118: 5429-38.
-
(2011)
Blood
, vol.118
, pp. 5429-5438
-
-
Wang, J.1
Han, F.2
Wu, J.3
-
37
-
-
84881192827
-
Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression
-
Chan CH, Morrow JK, Li CF, et al. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell 2013; 154: 556-68.
-
(2013)
Cell
, vol.154
, pp. 556-568
-
-
Chan, C.H.1
Morrow, J.K.2
Li, C.F.3
-
38
-
-
79951698621
-
FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation
-
Babaei-Jadidi R, Li N, Saadeddin A, et al. FBXW7 influences murine intestinal homeostasis and cancer, targeting Notch, Jun, and DEK for degradation. J Exp Med 2011; 208: 295-312.
-
(2011)
J Exp Med
, vol.208
, pp. 295-312
-
-
Babaei-Jadidi, R.1
Li, N.2
Saadeddin, A.3
-
39
-
-
2942707848
-
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
-
Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-39.
-
(2004)
Cell
, vol.117
, pp. 927-939
-
-
Yang, J.1
Mani, S.A.2
Donaher, J.L.3
-
41
-
-
4043052971
-
Epithelial-mesenchymal transitions: Twist in development and metastasis
-
Kang Y, Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 2004; 118: 277-9.
-
(2004)
Cell
, vol.118
, pp. 277-279
-
-
Kang, Y.1
Massague, J.2
-
42
-
-
84855478714
-
Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms
-
Qin Q, Xu Y, He T, Qin C, Xu J. Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res 2012; 22: 90-106.
-
(2012)
Cell Res
, vol.22
, pp. 90-106
-
-
Qin, Q.1
Xu, Y.2
He, T.3
Qin, C.4
Xu, J.5
-
43
-
-
79960283982
-
The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1
-
Lander R, Nordin K, LaBonne C. The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1. J Cell Biol 2011; 194: 17-25.
-
(2011)
J Cell Biol
, vol.194
, pp. 17-25
-
-
Lander, R.1
Nordin, K.2
Labonne, C.3
-
44
-
-
84881298549
-
Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis
-
Zhong J, Ogura K, Wang Z, Inuzuka H. Degradation of the transcription factor Twist, an oncoprotein that promotes cancer metastasis. Discov Med 2013; 15: 7-15.
-
(2013)
Discov Med
, vol.15
, pp. 7-15
-
-
Zhong, J.1
Ogura, K.2
Wang, Z.3
Inuzuka, H.4
-
45
-
-
5444269904
-
Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelialmesenchymal transition
-
Zhou BP, Deng J, Xia W, et al. Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelialmesenchymal transition. Nat Cell Biol 2004; 6: 931-40.
-
(2004)
Nat Cell Biol
, vol.6
, pp. 931-940
-
-
Zhou, B.P.1
Deng, J.2
Xia, W.3
-
46
-
-
77950505906
-
The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation
-
Vinas-Castells R, Beltran M, Valls G, et al. The hypoxia-controlled FBXL14 ubiquitin ligase targets SNAIL1 for proteasome degradation. J Biol Chem 2010; 285: 3794-805.
-
(2010)
J Biol Chem
, vol.285
, pp. 3794-3805
-
-
Vinas-Castells, R.1
Beltran, M.2
Valls, G.3
-
47
-
-
84904501583
-
Snail nuclear transport: The gateways regulating epithelial-tomesenchymal transition?
-
Muqbil I, Wu J, Aboukameel A, Mohammad RM, Azmi AS. Snail nuclear transport: The gateways regulating epithelial-tomesenchymal transition? Semin Cancer Biol 2014; 27C: 39-45.
-
(2014)
Semin Cancer Biol
, vol.27
, pp. 39-45
-
-
Muqbil, I.1
Wu, J.2
Aboukameel, A.3
Mohammad, R.M.4
Azmi, A.S.5
-
48
-
-
84893316763
-
Nuclear ubiquitination by FBXL5 modulates Snail1 DNA binding and stability
-
Vinas-Castells R, Frias A, Robles-Lanuza E, et al. Nuclear ubiquitination by FBXL5 modulates Snail1 DNA binding and stability. Nucleic Acids Res 2014; 42: 1079-94.
-
(2014)
Nucleic Acids Res
, vol.42
, pp. 1079-1094
-
-
Vinas-Castells, R.1
Frias, A.2
Robles-Lanuza, E.3
-
49
-
-
84890852964
-
The Role of Snail in EMT and Tumorigenesis
-
Wang Y, Shi J, Chai K, Ying X, Zhou BP. The Role of Snail in EMT and Tumorigenesis. Curr Cancer Drug Targets 2013; 13: 963-72.
-
(2013)
Curr Cancer Drug Targets
, vol.13
, pp. 963-972
-
-
Wang, Y.1
Shi, J.2
Chai, K.3
Ying, X.4
Zhou, B.P.5
-
50
-
-
80052403945
-
The EMT regulator slug and lung carcinogenesis
-
Shih JY, Yang PC. The EMT regulator slug and lung carcinogenesis. Carcinogenesis 2011; 32: 1299-304.
-
(2011)
Carcinogenesis
, vol.32
, pp. 1299-1304
-
-
Shih, J.Y.1
Yang, P.C.2
-
51
-
-
33749391866
-
Slug stability is dynamically regulated during neural crest development by the F-box protein Ppa
-
Vernon AE, LaBonne C. Slug stability is dynamically regulated during neural crest development by the F-box protein Ppa. Development 2006; 133: 3359-70.
-
(2006)
Development
, vol.133
, pp. 3359-3370
-
-
Vernon, A.E.1
Labonne, C.2
-
52
-
-
67349166210
-
P53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug
-
Wang SP, Wang WL, Chang YL, et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat Cell Biol 2009; 11: 694-704.
-
(2009)
Nat Cell Biol
, vol.11
, pp. 694-704
-
-
Wang, S.P.1
Wang, W.L.2
Chang, Y.L.3
-
53
-
-
34249289041
-
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype
-
Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7: 415-28.
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 415-428
-
-
Peinado, H.1
Olmeda, D.2
Cano, A.3
-
54
-
-
84871385387
-
ZEB/miR-200 feedback loop: At the crossroads of signal transduction in cancer
-
Hill L, Browne G, Tulchinsky E. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer. Int J Cancer 2013; 132: 745-54.
-
(2013)
Int J Cancer
, vol.132
, pp. 745-754
-
-
Hill, L.1
Browne, G.2
Tulchinsky, E.3
-
55
-
-
77950502330
-
ZEB proteins link cell motility with cell cycle control and cell survival in cancer
-
Browne G, Sayan AE, Tulchinsky E. ZEB proteins link cell motility with cell cycle control and cell survival in cancer. Cell Cycle 2010; 9: 886-91.
-
(2010)
Cell Cycle
, vol.9
, pp. 886-891
-
-
Browne, G.1
Sayan, A.E.2
Tulchinsky, E.3
-
56
-
-
82755165972
-
Expanding roles of ZEB factors in tumorigenesis and tumor progression
-
Sanchez-Tillo E, Siles L, de Barrios O, et al. Expanding roles of ZEB factors in tumorigenesis and tumor progression. Am J Cancer Res 2011; 1: 897-912.
-
(2011)
Am J Cancer Res
, vol.1
, pp. 897-912
-
-
Sanchez-Tillo, E.1
Siles, L.2
De Barrios, O.3
-
57
-
-
64249172203
-
The canonical Notch signaling pathway: Unfolding the activation mechanism
-
Kopan R, Ilagan MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 2009; 137: 216-33.
-
(2009)
Cell
, vol.137
, pp. 216-233
-
-
Kopan, R.1
Ilagan, M.X.2
-
58
-
-
33644752839
-
Notch signaling
-
Miele L. Notch signaling. Clin Cancer Res 2006; 12: 1074-9.
-
(2006)
Clin Cancer Res
, vol.12
, pp. 1074-1079
-
-
Miele, L.1
-
59
-
-
0142259346
-
The role of Notch in tumorigenesis: Oncogene or tumour suppressor?
-
Radtke F, Raj K. The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat Rev Cancer 2003; 3: 756-67.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 756-767
-
-
Radtke, F.1
Raj, K.2
-
60
-
-
84870954822
-
Epigenetic silencing of Notch signaling in gastrointestinal cancers
-
Piazzi G, Bazzoli F, Ricciardiello L. Epigenetic silencing of Notch signaling in gastrointestinal cancers. Cell Cycle 2012; 11: 4323-7.
-
(2012)
Cell Cycle
, vol.11
, pp. 4323-4327
-
-
Piazzi, G.1
Bazzoli, F.2
Ricciardiello, L.3
-
63
-
-
84859482643
-
Notch signaling and intestinal cancer
-
Guilmeau S. Notch signaling and intestinal cancer. Adv Exp Med Biol 2012; 727: 272-88.
-
(2012)
Adv Exp Med Biol
, vol.727
, pp. 272-288
-
-
Guilmeau, S.1
-
64
-
-
84859484455
-
Notch-signaling and nonmelanoma skin cancer: An ancient friend, revisited
-
Reichrath J, Reichrath S. Notch-signaling and nonmelanoma skin cancer: an ancient friend, revisited. Adv Exp Med Biol 2012; 727: 265-71.
-
(2012)
Adv Exp Med Biol
, vol.727
, pp. 265-271
-
-
Reichrath, J.1
Reichrath, S.2
-
65
-
-
84859506935
-
Notch signaling and malignant melanoma
-
Muller CS. Notch signaling and malignant melanoma. Adv Exp Med Biol 2012; 727: 258-64.
-
(2012)
Adv Exp Med Biol
, vol.727
, pp. 258-264
-
-
Muller, C.S.1
-
66
-
-
84859482094
-
Notch signaling and breast cancer
-
Reedijk M. Notch signaling and breast cancer. Adv Exp Med Biol 2012; 727: 241-57.
-
(2012)
Adv Exp Med Biol
, vol.727
, pp. 241-257
-
-
Reedijk, M.1
-
67
-
-
78951481235
-
Role of Notch and its oncogenic signaling crosstalk in breast cancer
-
Guo S, Liu M, Gonzalez-Perez RR. Role of Notch and its oncogenic signaling crosstalk in breast cancer. Biochim Biophys Acta 2011; 1815: 197-213.
-
(2011)
Biochim Biophys Acta
, vol.1815
, pp. 197-213
-
-
Guo, S.1
Liu, M.2
Gonzalez-Perez, R.R.3
-
68
-
-
50849111710
-
Rational targeting of Notch signaling in cancer
-
Rizzo P, Osipo C, Foreman K, et al. Rational targeting of Notch signaling in cancer. Oncogene 2008; 27: 5124-31.
-
(2008)
Oncogene
, vol.27
, pp. 5124-5131
-
-
Rizzo, P.1
Osipo, C.2
Foreman, K.3
-
69
-
-
84856008970
-
Notch signalling in cancer progression and bone metastasis
-
Sethi N, Kang Y. Notch signalling in cancer progression and bone metastasis. Br J Cancer 2011; 105: 1805-10.
-
(2011)
Br J Cancer
, vol.105
, pp. 1805-1810
-
-
Sethi, N.1
Kang, Y.2
-
70
-
-
84856088337
-
EMT and dissemination precede pancreatic tumor formation
-
Rhim AD, Mirek ET, Aiello NM, et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012; 148: 349-61.
-
(2012)
Cell
, vol.148
, pp. 349-361
-
-
Rhim, A.D.1
Mirek, E.T.2
Aiello, N.M.3
-
71
-
-
84859095585
-
Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells
-
Xie M, Zhang L, He CS, et al. Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells. J Cell Biochem 2012; 113: 1501-13.
-
(2012)
J Cell Biochem
, vol.113
, pp. 1501-1513
-
-
Xie, M.1
Zhang, L.2
He, C.S.3
-
72
-
-
79151479321
-
Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by upregulating Notch and NF-kappaB signaling pathways
-
Ahmad A, Wang Z, Kong D, et al. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by upregulating Notch and NF-kappaB signaling pathways. Breast Cancer Res Treat 2011; 126: 15-25.
-
(2011)
Breast Cancer Res Treat
, vol.126
, pp. 15-25
-
-
Ahmad, A.1
Wang, Z.2
Kong, D.3
-
73
-
-
48649098427
-
Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells
-
Kong D, Wang Z, Sarkar SH, et al. Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells. Stem Cells 2008; 26: 1425-35.
-
(2008)
Stem Cells
, vol.26
, pp. 1425-1435
-
-
Kong, D.1
Wang, Z.2
Sarkar, S.H.3
-
74
-
-
79957487931
-
Notch-1 induces epithelialmesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells
-
Bao B, Wang Z, Ali S, et al. Notch-1 induces epithelialmesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett 2011; 307: 26-36.
-
(2011)
Cancer Lett
, vol.307
, pp. 26-36
-
-
Bao, B.1
Wang, Z.2
Ali, S.3
-
76
-
-
84859270591
-
Notch signaling mediates TGF-beta1-induced epithelialmesenchymal transition through the induction of Snai1
-
Matsuno Y, Coelho AL, Jarai G, Westwick J, Hogaboam CM. Notch signaling mediates TGF-beta1-induced epithelialmesenchymal transition through the induction of Snai1. Int J Biochem Cell Biol 2012; 44: 776-89.
-
(2012)
Int J Biochem Cell Biol
, vol.44
, pp. 776-789
-
-
Matsuno, Y.1
Coelho, A.L.2
Jarai, G.3
Westwick, J.4
Hogaboam, C.M.5
-
77
-
-
1542409037
-
Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein
-
Tetzlaff MT, Yu W, Li M, et al. Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proc Natl Acad Sci USA 2004; 101: 3338-45.
-
(2004)
Proc Natl Acad Sci USA
, vol.101
, pp. 3338-3345
-
-
Tetzlaff, M.T.1
Yu, W.2
Li, M.3
-
78
-
-
1542364470
-
Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development
-
Tsunematsu R, Nakayama K, Oike Y, et al. Mouse Fbw7/Sel-10/Cdc4 is required for notch degradation during vascular development. J Biological Chem 2004; 279: 9417-23.
-
(2004)
J Biological Chem
, vol.279
, pp. 9417-9423
-
-
Tsunematsu, R.1
Nakayama, K.2
Oike, Y.3
-
79
-
-
58149202128
-
Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls
-
Baud V, Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nat Rev Drug Discov 2009; 8: 33-40.
-
(2009)
Nat Rev Drug Discov
, vol.8
, pp. 33-40
-
-
Baud, V.1
Karin, M.2
-
80
-
-
80052014052
-
Inflammation meets cancer, with NFkappaB as the matchmaker
-
Ben-Neriah Y, Karin M. Inflammation meets cancer, with NFkappaB as the matchmaker. Nat Immunol 2011; 12: 715-23.
-
(2011)
Nat Immunol
, vol.12
, pp. 715-723
-
-
Ben-Neriah, Y.1
Karin, M.2
-
81
-
-
33745298519
-
Nuclear factor-kappaB in cancer development and progression
-
Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006; 441: 431-6.
-
(2006)
Nature
, vol.441
, pp. 431-436
-
-
Karin, M.1
-
82
-
-
84855710408
-
The NFkappaB pathway: A therapeutic target in glioblastoma
-
Nogueira L, Ruiz-Ontanon P, Vazquez-Barquero A, Moris F, Fernandez-Luna JL. The NFkappaB pathway: a therapeutic target in glioblastoma. Oncotarget 2011; 2: 646-53.
-
(2011)
Oncotarget
, vol.2
, pp. 646-653
-
-
Nogueira, L.1
Ruiz-Ontanon, P.2
Vazquez-Barquero, A.3
Moris, F.4
Fernandez-Luna, J.L.5
-
83
-
-
80052887167
-
A critical role for the NFkB pathway in multiple myeloma
-
Demchenko YN, Kuehl WM. A critical role for the NFkB pathway in multiple myeloma. Oncotarget 2010; 1: 59-68.
-
(2010)
Oncotarget
, vol.1
, pp. 59-68
-
-
Demchenko, Y.N.1
Kuehl, W.M.2
-
84
-
-
84856213846
-
The diverse and complex roles of NF-kappaB subunits in cancer
-
Perkins ND. The diverse and complex roles of NF-kappaB subunits in cancer. Nat Rev Cancer 2012; 12: 121-32.
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 121-132
-
-
Perkins, N.D.1
-
85
-
-
84858718448
-
NF-kappaB and the link between inflammation and cancer
-
DiDonato JA, Mercurio F, Karin M. NF-kappaB and the link between inflammation and cancer. Immunol Rev 2012; 246: 379-400.
-
(2012)
Immunol Rev
, vol.246
, pp. 379-400
-
-
Didonato, J.A.1
Mercurio, F.2
Karin, M.3
-
86
-
-
84867289621
-
The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-kappaB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells
-
Walsby E, Pearce L, Burnett AK, Fegan C, Pepper C. The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-kappaB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells. Oncotarget 2012; 3: 525-34.
-
(2012)
Oncotarget
, vol.3
, pp. 525-534
-
-
Walsby, E.1
Pearce, L.2
Burnett, A.K.3
Fegan, C.4
Pepper, C.5
-
87
-
-
33846828787
-
NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: Potential involvement of ZEB-1 and ZEB-2
-
Chua HL, Bhat-Nakshatri P, Clare SE, et al. NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2. Oncogene 2007; 26: 711-24.
-
(2007)
Oncogene
, vol.26
, pp. 711-724
-
-
Chua, H.L.1
Bhat-Nakshatri, P.2
Clare, S.E.3
-
88
-
-
17144386589
-
Epithelial-mesenchymal transition: NF-kappaB takes center stage
-
Huber MA, Beug H, Wirth T. Epithelial-mesenchymal transition: NF-kappaB takes center stage. Cell Cycle 2004; 3: 1477-80.
-
(2004)
Cell Cycle
, vol.3
, pp. 1477-1480
-
-
Huber, M.A.1
Beug, H.2
Wirth, T.3
-
89
-
-
4344612243
-
NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression
-
Huber MA, Azoitei N, Baumann B, et al. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Investigation 2004; 114: 569-81.
-
(2004)
J Clin Investigation
, vol.114
, pp. 569-581
-
-
Huber, M.A.1
Azoitei, N.2
Baumann, B.3
-
90
-
-
84861668632
-
SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction
-
Fukushima H, Matsumoto A, Inuzuka H, et al. SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction. Cell Rep 2012; 1: 434-43.
-
(2012)
Cell Rep
, vol.1
, pp. 434-443
-
-
Fukushima, H.1
Matsumoto, A.2
Inuzuka, H.3
-
91
-
-
84859430011
-
Fbxw7alpha-and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
-
Busino L, Millman SE, Scotto L, et al. Fbxw7alpha-and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma. Nat Cell Biol 2012; 14: 375-85.
-
(2012)
Nat Cell Biol
, vol.14
, pp. 375-385
-
-
Busino, L.1
Millman, S.E.2
Scotto, L.3
-
92
-
-
84864837496
-
Proteomic screen reveals Fbw7 as a modulator of the NF-kappaB pathway
-
Arabi A, Ullah K, Branca RM, et al. Proteomic screen reveals Fbw7 as a modulator of the NF-kappaB pathway. Nat Commun 2012; 3: 976.
-
(2012)
Nat Commun
, vol.3
-
-
Arabi, A.1
Ullah, K.2
Branca, R.M.3
-
93
-
-
84893249799
-
PI3K and cancer: Lessons, challenges and opportunities
-
Fruman DA, Rommel C. PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 2014; 13: 140-56.
-
(2014)
Nat Rev Drug Discov
, vol.13
, pp. 140-156
-
-
Fruman, D.A.1
Rommel, C.2
-
94
-
-
0036632368
-
The phosphatidylinositol 3-Kinase AKT pathway in human cancer
-
Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2: 489-501.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 489-501
-
-
Vivanco, I.1
Sawyers, C.L.2
-
95
-
-
84874650275
-
Development of PI3K inhibitors: Lessons learned from early clinical trials
-
Rodon J, Dienstmann R, Serra V, Tabernero J. Development of PI3K inhibitors: lessons learned from early clinical trials. Nat Rev Clin Oncol 2013; 10: 143-53.
-
(2013)
Nat Rev Clin Oncol
, vol.10
, pp. 143-153
-
-
Rodon, J.1
Dienstmann, R.2
Serra, V.3
Tabernero, J.4
-
96
-
-
32044466838
-
Exploiting the PI3K/AKT pathway for cancer drug discovery
-
Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov 2005; 4: 988-1004.
-
(2005)
Nat Rev Drug Discov
, vol.4
, pp. 988-1004
-
-
Hennessy, B.T.1
Smith, D.L.2
Ram, P.T.3
Lu, Y.4
Mills, G.B.5
-
97
-
-
0037728809
-
The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines
-
Grille SJ, Bellacosa A, Upson J, et al. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 2003; 63: 2172-8.
-
(2003)
Cancer Res
, vol.63
, pp. 2172-2178
-
-
Grille, S.J.1
Bellacosa, A.2
Upson, J.3
-
98
-
-
36349011403
-
Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition
-
Julien S, Puig I, Caretti E, et al. Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 2007; 26: 7445-56.
-
(2007)
Oncogene
, vol.26
, pp. 7445-7456
-
-
Julien, S.1
Puig, I.2
Caretti, E.3
-
99
-
-
84861552793
-
The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis
-
Chan CH, Li CF, Yang WL, et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesis. Cell 2012; 149: 1098-111.
-
(2012)
Cell
, vol.149
, pp. 1098-1111
-
-
Chan, C.H.1
Li, C.F.2
Yang, W.L.3
-
100
-
-
33747819801
-
MTOR and cancer: Insights into a complex relationship
-
[100] Sabatini DM. mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 2006; 6: 729-34.
-
(2006)
Nat Rev Cancer
, vol.6
, pp. 729-734
-
-
Sabatini, D.M.1
-
101
-
-
54549089738
-
Hypoxia signalling through mTOR and the unfolded protein response in cancer
-
[101] Wouters BG, Koritzinsky M. Hypoxia signalling through mTOR and the unfolded protein response in cancer. Nat Rev Cancer 2008; 8: 851-64.
-
(2008)
Nat Rev Cancer
, vol.8
, pp. 851-864
-
-
Wouters, B.G.1
Koritzinsky, M.2
-
102
-
-
78650510609
-
MTOR: From growth signal integration to cancer, diabetes and ageing
-
[102] Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12: 21-35.
-
(2011)
Nat Rev Mol Cell Biol
, vol.12
, pp. 21-35
-
-
Zoncu, R.1
Efeyan, A.2
Sabatini, D.M.3
-
104
-
-
84941745204
-
MTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer
-
[104] Chen X, Cheng H, Pan T, et al. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer. Mol Carcinog 2014. doi: 10.1002/mc.22177
-
(2014)
Mol Carcinog
-
-
Chen, X.1
Cheng, H.2
Pan, T.3
-
105
-
-
84903379888
-
Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition
-
[105] Zong H, Yin B, Zhou H, et al. Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition. Mol Biol Rep 2014; 41: 4507-12.
-
(2014)
Mol Biol Rep
, vol.41
, pp. 4507-4512
-
-
Zong, H.1
Yin, B.2
Zhou, H.3
-
106
-
-
84887495550
-
Acquisition of epithelialmesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance
-
[106] Chang L, Graham PH, Hao J, et al. Acquisition of epithelialmesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance. Cell Death Disease 2013; 4: e875.
-
(2013)
Cell Death Disease
, vol.4
-
-
Chang, L.1
Graham, P.H.2
Hao, J.3
-
107
-
-
51749095471
-
FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression
-
[107] Mao JH, Kim IJ, Wu D, et al. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 2008; 321: 1499-502.
-
(2008)
Science
, vol.321
, pp. 1499-1502
-
-
Mao, J.H.1
Kim, I.J.2
Wu, D.3
-
108
-
-
67349241955
-
DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival
-
[108] Peterson TR, Laplante M, Thoreen CC, et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell 2009; 137: 873-86.
-
(2009)
Cell
, vol.137
, pp. 873-886
-
-
Peterson, T.R.1
Laplante, M.2
Thoreen, C.C.3
-
109
-
-
81855228182
-
MTOR generates an autoamplification loop by triggering the betaTrCP-and CK1alphadependent degradation of DEPTOR
-
[109] Duan S, Skaar JR, Kuchay S, et al. mTOR generates an autoamplification loop by triggering the betaTrCP-and CK1alphadependent degradation of DEPTOR. Mol Cell 2011; 44: 317-24.
-
(2011)
Mol Cell
, vol.44
, pp. 317-324
-
-
Duan, S.1
Skaar, J.R.2
Kuchay, S.3
-
110
-
-
81855181738
-
MTOR drives its own activation via SCF(betaTrCP)-dependent degradation of the mTOR inhibitor DEPTOR
-
[110] Gao D, Inuzuka H, Tan MK, et al. mTOR drives its own activation via SCF(betaTrCP)-dependent degradation of the mTOR inhibitor DEPTOR. Mol Cell 2011; 44: 290-303.
-
(2011)
Mol Cell
, vol.44
, pp. 290-303
-
-
Gao, D.1
Inuzuka, H.2
Tan, M.K.3
-
111
-
-
81855167585
-
DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(betaTrCP) E3 ubiquitin ligase and regulates survival and autophagy
-
[111] Zhao Y, Xiong X, Sun Y. DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(betaTrCP) E3 ubiquitin ligase and regulates survival and autophagy. Mol Cell 2011; 44: 304-16.
-
(2011)
Mol Cell
, vol.44
, pp. 304-316
-
-
Zhao, Y.1
Xiong, X.2
Sun, Y.3
-
112
-
-
0036559186
-
Gli and hedgehog in cancer: Tumours, embryos and stem cells
-
[112] Ruiz i Altaba A, Sanchez P, Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer 2002; 2: 361-72.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 361-372
-
-
Ruiz I Altaba, A.1
Sanchez, P.2
Dahmane, N.3
-
113
-
-
33751549095
-
Targeting the Hedgehog pathway in cancer
-
[113] Rubin LL, de Sauvage FJ. Targeting the Hedgehog pathway in cancer. Nat Rev Drug Discov 2006; 5: 1026-33.
-
(2006)
Nat Rev Drug Discov
, vol.5
, pp. 1026-1033
-
-
Rubin, L.L.1
De Sauvage, F.J.2
-
114
-
-
80955181031
-
The Hedgehog's tale: Developing strategies for targeting cancer
-
[114] Ng JM, Curran T. The Hedgehog's tale: developing strategies for targeting cancer. Nat Rev Cancer 2011; 11: 493-501.
-
(2011)
Nat Rev Cancer
, vol.11
, pp. 493-501
-
-
Ng, J.M.1
Curran, T.2
-
115
-
-
0345059765
-
Hedgehog signalling in cancer formation and maintenance
-
[115] Pasca di Magliano M, Hebrok M. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer 2003; 3: 903-11.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 903-911
-
-
Pasca Di Magliano, M.1
Hebrok, M.2
-
116
-
-
84905001546
-
Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition (EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells
-
[116] Xu X, Su B, Xie C, et al. Sonic hedgehog-Gli1 signaling pathway regulates the epithelial mesenchymal transition (EMT) by mediating a new target gene, S100A4, in pancreatic cancer cells. PLoS One 2014; 9: e96441.
-
(2014)
Plos One
, vol.9
-
-
Xu, X.1
Su, B.2
Xie, C.3
-
117
-
-
84903466928
-
Down-regulation of Gli-1 inhibits hepatocellular carcinoma cell migration and invasion
-
[117] Chen JS, Li HS, Huang JQ, et al. Down-regulation of Gli-1 inhibits hepatocellular carcinoma cell migration and invasion. Mol Cell Biochem 2014; 393: 283-91.
-
(2014)
Mol Cell Biochem
, vol.393
, pp. 283-291
-
-
Chen, J.S.1
Li, H.S.2
Huang, J.Q.3
-
118
-
-
84901463458
-
Hedgehog/Gli promotes epithelialmesenchymal transition in lung squamous cell carcinomas
-
[118] Yue D, Li H, Che J, et al. Hedgehog/Gli promotes epithelialmesenchymal transition in lung squamous cell carcinomas. J Exp Clin Cancer Res 2014; 33: 34.
-
(2014)
J Exp Clin Cancer Res
, vol.33
-
-
Yue, D.1
Li, H.2
Che, J.3
-
119
-
-
33745858643
-
Gli2 is targeted for ubiquitination and degradation by beta-TrCP ubiquitin ligase
-
[119] Bhatia N, Thiyagarajan S, Elcheva I, et al. Gli2 is targeted for ubiquitination and degradation by beta-TrCP ubiquitin ligase. J Biological Chem 2006; 281: 19320-6.
-
(2006)
J Biological Chem
, vol.281
, pp. 19320-19326
-
-
Bhatia, N.1
Thiyagarajan, S.2
Elcheva, I.3
-
120
-
-
33751208606
-
Regulation of Hh/Gli signaling by dual ubiquitin pathways
-
[120] Jiang J. Regulation of Hh/Gli signaling by dual ubiquitin pathways. Cell Cycle 2006; 5: 2457-63.
-
(2006)
Cell Cycle
, vol.5
, pp. 2457-2463
-
-
Jiang, J.1
-
121
-
-
84655161946
-
HIF1alpha and HIF2alpha: Sibling rivalry in hypoxic tumour growth and progression
-
[121] Keith B, Johnson RS, Simon MC. HIF1alpha and HIF2alpha: sibling rivalry in hypoxic tumour growth and progression. Nat Rev Cancer 2012; 12: 9-22.
-
(2012)
Nat Rev Cancer
, vol.12
, pp. 9-22
-
-
Keith, B.1
Johnson, R.S.2
Simon, M.C.3
-
122
-
-
40949142209
-
The role of hypoxia-inducible factors in tumorigenesis
-
[122] Rankin EB, Giaccia AJ. The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008; 15: 678-85.
-
(2008)
Cell Death Differ
, vol.15
, pp. 678-685
-
-
Rankin, E.B.1
Giaccia, A.J.2
-
123
-
-
80053532392
-
Hypoxia-inducible factor-1alpha expression and gemcitabine chemotherapy for pancreatic cancer
-
[123] Kasuya K, Tsuchida A, Nagakawa Y, et al. Hypoxia-inducible factor-1alpha expression and gemcitabine chemotherapy for pancreatic cancer. Oncol Rep 2011; 26: 1399-406.
-
(2011)
Oncol Rep
, vol.26
, pp. 1399-1406
-
-
Kasuya, K.1
Tsuchida, A.2
Nagakawa, Y.3
-
124
-
-
57349164238
-
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells
-
[124] Cannito S, Novo E, Compagnone A, et al. Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis 2008; 29: 2267-78.
-
(2008)
Carcinogenesis
, vol.29
, pp. 2267-2278
-
-
Cannito, S.1
Novo, E.2
Compagnone, A.3
-
125
-
-
80051927592
-
Nuclear factor-kappaBdependent epithelial to mesenchymal transition induced by HIF-1alpha activation in pancreatic cancer cells under hypoxic conditions
-
[125] Cheng ZX, Sun B, Wang SJ, et al. Nuclear factor-kappaBdependent epithelial to mesenchymal transition induced by HIF-1alpha activation in pancreatic cancer cells under hypoxic conditions. PLoS One 2011; 6: e23752.
-
(2011)
Plos One
, vol.6
-
-
Cheng, Z.X.1
Sun, B.2
Wang, S.J.3
-
126
-
-
84903749390
-
Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1alpha in pancreatic cancer cells
-
[126] Wang R, Cheng L, Xia J, Wang Z, Wu Q. Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1alpha in pancreatic cancer cells. Curr Cancer Drug Targets 2014; 14: 407-17.
-
(2014)
Curr Cancer Drug Targets
, vol.14
, pp. 407-417
-
-
Wang, R.1
Cheng, L.2
Xia, J.3
Wang, Z.4
Wu, Q.5
-
127
-
-
80055019700
-
Negative regulation of HIF-1alpha by an FBW7-mediated degradation pathway during hypoxia
-
[127] Cassavaugh JM, Hale SA, Wellman TL, et al. Negative regulation of HIF-1alpha by an FBW7-mediated degradation pathway during hypoxia. J Cell Biochem 2011; 112: 3882-90.
-
(2011)
J Cell Biochem
, vol.112
, pp. 3882-3890
-
-
Cassavaugh, J.M.1
Hale, S.A.2
Wellman, T.L.3
-
128
-
-
84899557305
-
Glycogen synthase kinase-3beta regulates cell growth, migration and angiogenesis via Fbw7 and USP-28-dependent degradation of hypoxia-inducible factor-1alpha
-
[128] Flugel D, Gorlach A, Kietzmann T. Glycogen synthase kinase-3beta regulates cell growth, migration and angiogenesis via Fbw7 and USP-28-dependent degradation of hypoxia-inducible factor-1alpha. Blood 2011.
-
(2011)
Blood
-
-
Flugel, D.1
Gorlach, A.2
Kietzmann, T.3
|